Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 17:35:25
Intl Biotech (IBT.L, London)
Závěr k 13.2.2026 Změna (%) Změna (GBP) Objem obchodů (GBP)
8,92 0,90 0,08 53 139
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiInternational Biotechnology Trust Plc
TickerIBT
Kmenové akcie:Ordinary Shares
RICIBT.L
ISINGB0004559349
Poslední známé roční výsledky31.08.2025
Poslední známé čtvrtletní výsledky31.08.2025
Počet zaměstnanců k 31.08.2025 0
Akcie v oběhu k 25.11.2025 31 902 834
MěnaGBP
Kontaktní informace
Ulice6th Floor, 65 Gresham Street,
MěstoLONDON
PSČEC2V 7NQ
ZeměUnited Kingdom
Kontatní osoba 
Funkce kontaktní osoby 
Telefon442 074 217 070

Business Summary: International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and potential upside through the development and/or commercialization of a product, device or enabling technology. Its investments may also be made in related sectors, such as medical devices and healthcare services. It may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Schroder Investment Management Limited is the investment manager of the Company. Schroder Unit Trusts Limited is the alternative investment fund manager of the Company.
Financial Summary: BRIEF: For the fiscal year ended 31 August 2025, International Biotechnology Trust Plc revenues decreased 86% to L6.1M. Net loss totaled L1.2M vs. income of L38.9M. Revenues reflect Unquoted investments decrease from L5.5M to -L13.4M, Losses)/gains on investments held at fai decrease of 50% to L18.2M, Realized Foreign Exchange G/L - Capital decrease of 51% to L819K. Dividend per share increased from L0.28 to L0.32.
Odvětvová klasifikace
TRBC2012UK Investment Trusts
RBSS2004Biotechnology
MGINDUSTRYMisc. Financial Services
MGSECTORFinancial
NAICSOther Financial Vehicles
NAICS2007Other Financial Vehicles
NAICS1997Other Financial Vehicles
SICInvestment Offices, Nec



  • Poslední aktualizace: 01.01.0001
Management společnosti
Data nejsou k dispozici